Intracellular demonstration of active TGFβ1 in B cells and plasma cells of autoimmune mice: IgG-bound TGFβ1 suppresses neutrophil function and host defense against Staphylococcus aureus infection

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2496-2506

  Caver, Tony E ^a,b   O'Sullivan, Frank X ^a,b   Gold, Leslie I ^c   Gresham, Hattie D ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

B cells; phagocytosis; polymorphonuclear cells; systemic lupus erythematosus; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; CELL FUNCTION; CELL SURVIVAL; COMPLEX FORMATION; GLOMERULONEPHRITIS; HOST RESISTANCE; KIDNEY FUNCTION; NONHUMAN; PHAGOCYTOSIS; PLASMA CELL; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029808482     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119068     Document Type: Article

References (44)

1. Staples, P.J., D.N. Gerding, J.L. Decker, and R.S. Gordon. 1974. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum. 17:1-10.
2. Rosner, S., E.M. Ginzler, H.S. Diamond, M. Weiner, M. Schlesinger, J.F. Fries, C. Wasner, T.A. Medsger, Jr., G. Ziegler, J.H. Klippel, et al. 1982. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 25:612-617.
3. Nived, O., G. Sturfelt, and F. Wollheim. 1985. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiologic group. Q. J. Med. 55:271-287.
4. Abu-Shakra, M., B. Urowits, D. Gladman, and J. Gough. 1995. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J. Rheumatol. 22:1259-1264.
5. Reveille, J., A. Bartolucci, and G.S. Alarcon. 1990. Prognosis and systemic lupus erythematosus. Arthritis Rheum. 33:37-48.
6. Pistiner, M., D.J. Wallace, S. Nessin, A.L. Metzger, and J.R. Klineberg. 1991. Lupus erythematosus in the 1980's: a survey of 570 patients. Semin. Arthritis Rheum. 21:55-64.
7. Dale, D., and R. Petersdorf. 1973. Corticosteroids and infectious diseases. Med. Clin. North Am. 57:1277-1287.
8. Watanabe-Duffy, K.N., D.M. Duffy, and D.D. Gladman. 1991. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J. Rheumatol. 18:1180-1184.
9. Gresham, H.D., C.J. Ray, and F. X. O'Sullivan. 1991. Defective neutrophil function in the autoimmune mouse strain MRL/lpr: potential role of transforming growth factor-β. J. Immunol. 146:3911-3921.
10. Lowrance, J., F. O'Sullivan, T. Caver, W. Waegell, and H.D. Gresham. 1994. Spontaneous elaboration of transforming growth factor-β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
11. Wahl, S. 1994. Transforming growth factor β. The good, the bad, the ugly. J. Exp. Med. 180:1587-1590.
12. Dang, H., A.G. Geiser, J.J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGFβ knockout mice. J. Immunol. 155: 3205-3212.
13. Yaswen, L., A.B. Kulkarni, T. Fredrickson, B. Mittleman, R. Schiffmann, S. Payne, G. Longenecker, E. Mozes, and S. Karlsson. 1996. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood. 87:1439-1445.
14. Sanderson, N., V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. Roberts, M. Sporn, and S. Thorgeirsson. 1995. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA. 92:2572-2576.
15. Raz, E., M. Lotz, S. Baird, R. Eisenberg, I. Wicks, and D. Carson. 1993. Modulation of murine systemic lupus erythematosus by cytokine gene delivery. Arthritis Rheum. 36:S91a. (Abstr.)
16. Kuruvilla, A.P., R. Shah, G.M. Hochwald, H.D. Liggitt, M. Palladino, and G.J. Thorbecke. 1991. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88: 2918-2921.
17. Border, W.A., S. Okuda, L. Languino, M.B. Sporn, and E. Ruoslahti. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature (Lond.). 346:371-374.
18. Brandes, M.E., J.B. Allen, Y. Ogawa, and S.M. Wahl. 1991. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1108-1113.
19. Allen, J.B., C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworlh, and S.M. Wahl. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J. Exp. Med. 171:231-247.
20. Chen, Y., V.K. Kuchroo, J.-I. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (Wash. DC). 265:1237-1240.
21. Stach, R.M., and D.A. Rowley. 1993. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178: 841-852.
22. Bouchard, C., A. Galinha, E. Tartour, W.H. Fridman, and C. Sautes. 1995. A transforming growth factor β-like immunosuppressive factor in immunoglobulin G-binding factor. J. Exp. Med. 182:1717-1726.
23. Rowley, D.A., E.T. Becken, and R.M. Stach. 1995. Autoantibodies produced spontaneously by young lpr mice carry transforming growth factor β and suppress cytotoxic T lymphocyte responses. J. Exp. Med. 181:1875-1880.
24. Satoh, M., A. Kumar, Y.S. Kanwar, and W.H. Reeves. 1995. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Prof. Natl. Acad. Sci. USA. 92:10934-10939.
25. Dasch, J.R., D.R. Pace, W. Waegell, D. Inenaga, and L. Ellingsworth. 1989. Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β2 affinity purification. J. Immunol. 142:1536-1541.
26. Danielpour, D. 1993. Improved sandwich enzyme-linked immunoabsorbent assays for transforming growth factor β1. J. Immunol. Methods. 158:17-25.
27. Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J.E. Murphy-Ullrich. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor β in a chemically defined system. J. Biol. Chem. 269: 26775-26781.
28. Pelton, R.W., B. Saxena, M. Jones, H.L. Moses, and L.I. Gold. 1991. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo. Expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1091-1105.
29. Nunes, I., R.L. Shapiro, and D.B. Rifkin. 1995. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155: 1450-1459.
30. Goddard, D.H., A.P. Kirk, J.R. Kirwan, G.D. Johnson, and E.J. Holborow. 1984. Impaired polymorphonuclear leukocyte chemotaxis in rheumatoid arthritis. Ann. Rheum. Dis. 43:151-156.
31. Wandall, J.H. 1985. Leukocyte function in patients with rheumatoid arthritis: quantitative in vivo leukocyte mobilization and in vitro functions of blood and exudate leukocytes. Ann. Rheum. Dis. 44:694-700.
32. Wheat, L.J. 1980. Infection and diabetes mellitus. Diabetes Care. 3:187-197.
33. Wilson, R.M., and W.G. Reeves. 1986. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin. Exp. Immunol. 63 478-484.
34. Witt, D.J., D.E. Craven, and W.R. McCabe. 1987. Bacterial infections in adult patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am. J. Med. 82:900-906.
35. Ellis, M., S. Gupta, and S. Galant. 1988. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268-1276.
36. Lim, S.H., F.J. Giles, M.P. Smith, and A.M. Goldstone. 1991. Bacterial infections in lymphoma patients treated with recombinant interleukin-2. Acta Haematol. (Basel). 85:135-138.
37. Snydman, D.R., B. Sullivan, M. Gill, J.A. Gould, D.R. Parkinson, and M.B. Atkins. 1990. Nosocomial sepsis associated with interleukin-2. Ann. Intern. Med. 112:102-107.
38. Puolakkainen, P., D. Twardzik, J. Ranchalis, M. Moroni, J. Mandeli, and P.A. Paciucci. 1995. Increase of plasma transforming growth factor beta (TGFβ) during immunotherapy with IL-2. Cancer Invest. 3:583-589.
39. Allen, J.B., H.L. Wong, P.M. Guyre, G.L. Simon, and S.M. Wahl. 1991. Association of circulating FcyRIII-positive monocytes ir AIDS patients wish elevated levels of transforming growth factor-β. J. Clin. Invest. 87:1773-1779.
40. Lotz, M., and P. Seth. 1993. TGFβ and HIV infection. Ann. NY Acad. Sci. 685:501-511.
41. Weiner, H.L., J. Inobe, V. Kuchroo, and Y. Chen. 1996. Induction and characterization of TGF-beta secreting Th3 cells. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:2558a. (Abstr.)
42. Huang, F.P., G.J. Feng, G. Lindop, D.I. Scott, and F.Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 83:1447-1459.
43. Brandes, M.E., U.E. Mai, K. Ohura, and S.M. Wahl. 1991. Human neutrophils express type I TGFβ receptors and chemotax to TGFβ. J. Immunol. 147:1600-1606.
44. Parekh, T., B. Saxena, J. Reibman, B.N. Cronstein, and L. Gold. 1994. Neutrophil chemotaxis in response to TGFβ isotorms (TCFβ1, TGFβ2. TGFβ) is mediated by fibronectin. J. Immunol. 152:2456-2466.